Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Epidermolysis bullosa in UK calves is not caused by mutations in keratin genes.

Baricitinib is a safe and effective treatment for severe alopecia areata.

Keeping β-catenin levels high in mammary cells disrupts their development and branching.

Researchers found a new gene variant linked to a rare bone disease, which doesn't always cause symptoms in carriers.

A specific genetic trait in tumor cells is linked to longer survival without disease in certain lymphoma patients.

The extracellular matrix affects where tumors can start in the body.

Bioregulatory medicine improved the dog's health and recovery from chemotherapy side effects.

Patients with fewer past treatments for alopecia areata respond better to baricitinib.

TGF-β and TNF influence hair follicle cell fate, with TNF being more effective in triggering cell death.

Adults with Beta Thalassemia Major are more likely to have skin, hair, and nail disorders.

The document concludes that detailed clinical descriptions of seven family cases help understand dominant dystrophic epidermolysis bullosa's symptoms and inheritance.

Biofeedback treatment for dysfunctional voiding in adults showed no symptom improvement.

Baricitinib significantly improves nail and hair symptoms in severe alopecia areata.

The document concludes that a new biosensor can efficiently detect prostate cancer cells and that standardized referrals help find significant cancers effectively.

Epidermolysis bullosa in calves was not caused by mutations in the keratin genes bKRT5 and bKRT14.

BPH management needs better long-term studies and prevention strategies.